Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice

Research output: Contribution to journalArticleScientificpeer-review

M. Garofalo, A. Villa, N. Rizzi, L. Kuryk, B. Rinner, Vincenzo Cerullo, M. Yliperttula, Vincenzo Mazzaferro, P. Ciana

JournalJournal of Controlled Release
Number of pages11
Publication statusPublished - 28 Jan 2019
MoE publication typeA1 Journal article-refereed

    Research areas

  • Extracellular vesicles, Oncolytic adenoviruses, Drug delivery, Lung cancer, Immunocompetent cancer mouse models, In vivo imaging, SYNERGISTIC ANTITUMOR EFFICACY, CARE CHEMOTHERAPY, HUMAN MACROPHAGES, IMMUNE-RESPONSES, CANCER-THERAPY, CURRENT STATE, MICROVESICLES, EXOSOMES, BIODISTRIBUTION, CELLS
  • 116 Chemical sciences
  • 317 Pharmacy
  • 3122 Cancers

External organisations

Garofalo, M.
  • University of Milan
Villa, A.
  • University of Milan
Rizzi, N.
  • University of Milan
Kuryk, L.
  • Targovax Oy, Dept Clin Sci
  • National Institute of Public Health—National Institute of Hygiene
Rinner, B.
  • Medical University of Graz
Mazzaferro, Vincenzo
  • University of Milan
  • Fondazione IRCCS Istituto Nazionale Tumori
Ciana, P.
  • University of Milan

ID: 121916115